Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both NF1 and Homozygous RET Proto-oncogen Germ-line Mutations
Cases of neurofibromatosis type 1 (NF1)-associated medullary thyroid carcinoma (MTC) or C-cell hyperplasia are rarely associated with other endocrine tumors or cases with a multiple endocrine neoplasia type 2. In these patients, mutations were detected in the NF1 gene but no mutations were detected...
Saved in:
Main Authors: | Begümhan Demir Gündoğan (Author), Fatih Sağcan (Author), Sevcan Tuğ Bozdoğan (Author), Yüksel Balcı (Author), Ferah Tuncel Daloğlu (Author), Elvan Cağlar Çıtak (Author) |
---|---|
Format: | Book |
Published: |
Galenos Yayincilik,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multiple endocrine neoplasias type 2B and RET proto-oncogene
by: Martucciello Giuseppe, et al.
Published: (2012) -
A study on genetic polymorphism of RET proto-oncogene in Hirschsprung's disease in children
by: Madhu Kumari, et al.
Published: (2020) -
Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.
by: Sara Sheikholeslami, et al.
Published: (2014) -
A PCR-mutagenesis strategy for rapid detection of mutations in codon 634 of the <it>ret</it> proto-oncogene related to MEN 2A.
by: Godoy Clara, et al.
Published: (2002) -
Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer
by: Ecem Bostan, et al.
Published: (2022)